35^th International Diabetes and Healthcare Conference

Welcome Message

It is our pleasure to invite the global diabetes and healthcare community to the 35^th International Diabetes and Healthcare Conference, taking place on June 15–16, 2026, in Paris, France.

Under the theme “Building a Sustainable and Inclusive Approach to Diabetes Care and Prevention,” the conference brings together diverse perspectives to address long-term challenges in diabetes management. Discussions will reflect how evolving patterns of glucose regulation influence patient outcomes across populations. Researchers will also examine how changes in insulin sensitivity affect disease progression, while clinicians focus on practical strategies for care delivery. Broader conversations will consider the role of metabolic adaptation in prevention models and the growing relevance of healthcare sustainability in global diabetes initiatives.

The program is designed to encourage meaningful dialogue through expert talks, interactive discussions, and collaborative sessions that connect research insights with real-world healthcare needs. We look forward to welcoming participants to Paris for an engaging exchange of knowledge that supports sustainable progress in diabetes care.

Target Audience

• Endocrinologists and Diabetologists
• Physicians in Internal Medicine and Primary Care
• Clinical and Translational Researchers
• Public Health Specialists
• Diabetes Educators
• Nutritionists and Lifestyle Medicine Professionals
• Epidemiologists
• Genetic and Molecular Researchers
• Pharmacology Specialists
• Digital Health and AI Experts
• Biomedical Engineers
• Medical Device Developers
• Pharmaceutical and Biotech Industry Professionals
• Healthcare Policymakers
• Hospital Administrators
• Academic Faculty
• Clinical Fellows and Residents
• Postgraduate Trainees
• PhD Scholars
• Graduate Students

About Conference

The 35^th International Diabetes and Healthcare Conference, scheduled for June 15–16, 2026, in Paris, France, is an international platform focused on advancing diabetes care through research, innovation, and collaboration.

Anchored in the theme “Building a Sustainable and Inclusive Approach to Diabetes Care and Prevention,” the conference explores how scientific discovery can be translated into practical healthcare solutions. Sessions will examine the impact of glycemic variability on long-term complications, while also addressing how beta-cell function evolves across different disease stages. Public health perspectives will highlight the importance of epidemiological trends in shaping prevention strategies, alongside discussions on therapeutic adherence and its influence on outcomes. Emerging care models will also consider the integration of population-based interventions into routine practice.

By bringing together clinicians, researchers, educators, industry professionals, and policymakers, the conference fosters collaboration across disciplines. It provides a platform to share research findings, exchange perspectives, and shape future directions in global diabetes management.

Why Attend

The 35^th International Diabetes and Healthcare Conference offers an opportunity to engage with current scientific thinking and practical approaches in diabetes care and prevention.

Participants will gain insight into how metabolic control influences disease trajectories and how early interventions can reduce long-term complications. Sessions will address the clinical implications of cardiovascular risk in diabetes, alongside discussions on emerging tools that support personalized care. The program also explores how advances in digital monitoring are shaping modern diabetes management and improving patient engagement.

In addition, the conference provides a platform to understand how healthcare systems can adapt to the rising global burden of diabetes. Discussions will highlight strategies that balance clinical effectiveness with population health planning, encouraging sustainable models of care that are adaptable across diverse healthcare settings.

The meeting creates a valuable environment to exchange knowledge, strengthen professional networks, and remain aligned with evolving global priorities in diabetes and healthcare

Conference Highlights

• Global Experts in Diabetes & Healthcare: Engage with internationally recognized scientists, clinicians, and public health leaders advancing diabetes research, prevention strategies, and clinical innovation.
   
• Advanced Scientific Sessions: In-depth discussions on metabolic syndrome, endocrine signaling, therapeutic optimization, and emerging care models.
   
• Workshops & Interactive Panels: Expert-led sessions focused on lifestyle intervention science, digital monitoring tools, and patient-centered care frameworks.
   
• Healthcare Innovation & Industry Showcase: Explore novel diagnostics, glucose monitoring technologies, digital platforms, and therapeutic solutions presented by leading industry partners.
   
• Young Researchers & Early-Career Forum: Dedicated sessions for students, fellows, and early-career professionals to present research, receive expert feedback, and gain international exposure.
   
• Networking & Multidisciplinary Collaboration: Connect with healthcare professionals, researchers, policymakers, and industry leaders to foster collaboration across diabetes and healthcare domains.
   
• Awards & Scientific Recognition: Honors including Best Research Presentation, Young Investigator Award, Best Clinical Innovation, and Best Poster Presentation.

Sessions and Tracks

Track 1: Molecular Mechanisms of Diabetes Progression

Diabetes development is driven by complex molecular signaling disruptions over time. Altered insulin transduction pathways reduce cellular glucose uptake efficiency. Persistent metabolic stress promotes glucotoxicity, damaging pancreatic function. Changes in phosphorylation cascades affect receptor sensitivity. Long-term imbalance accelerates systemic complications.

Exploration Points:

• Cellular Signaling Alterations
• Receptor Sensitivity Decline
• Molecular Disease Onset Models

Track 2: Beta Cell Biology & Functional Preservation

Pancreatic beta cells adapt continuously to metabolic demand. Chronic overload disrupts proinsulin folding, reducing hormone output. Elevated endoplasmic reticulum stress accelerates cell exhaustion. Altered islet cytoarchitecture weakens coordinated secretion. Protective strategies aim to enhance cellular resilience mechanisms. Preserving beta-cell function remains central to long-term disease control.

Research Streams:

• Beta Cell Survival Pathways
• Islet Structural Integrity
• Hormone Secretion Stability

Track 3: Insulin Resistance & Metabolic Flexibility

Insulin resistance arises from impaired cellular responsiveness. Increased lipotoxic intermediates interfere with glucose transport. Skeletal muscle exhibits altered mitochondrial bioenergetics under chronic metabolic load. Inflammatory signals modify substrate oxidation balance. Enhancing metabolic plasticity improves glycemic outcomes and slows disease progression.

Focus Areas:

• Tissue Glucose Uptake
• Energy Utilization Shifts
• Resistance Reversal Strategies

Track 4: Inflammatory Pathways in Diabetes

Low-grade inflammation sustains metabolic dysfunction. Elevated cytokine polarization disrupts insulin signaling. Immune cells release chemokine gradients that worsen tissue sensitivity. Persistent activation of inflammasome complexes accelerates vascular damage. Modulating immune-metabolic crosstalk is essential for reducing long-term complications.

Discussion Segments:

• Chronic Inflammation Drivers
• Immune Signal Regulation
• Anti-Inflammatory Therapies

Track 5: Genetic Architecture of Diabetes Risk

Genetic predisposition plays a major role in diabetes susceptibility. Variants influencing allelic penetrance alter glucose regulation. Epigenetic shifts modify chromatin accessibility in metabolic genes. Disrupted transcriptional fidelity affects insulin pathways. Understanding heritability gradients supports early screening and personalized prevention strategies.

Genomic Focus Areas:

• Risk Gene Mapping
• Epigenetic Influence Models
• Predictive Genetic Tools

Track 6: Gestational Diabetes & Maternal Health

Pregnancy introduces unique metabolic challenges for women. Placental hormones influence glycemic adaptability. Altered fetoplacental signaling increases maternal insulin demand. Persistent hormonal flux patterns elevate postpartum diabetes risk. Monitoring metabolic imprinting effects improves outcomes for both mother and child.

Maternal Care Modules:

• Pregnancy-Specific Risks
• Post-Delivery Metabolic Recovery
• Fetal Health Correlations

Track 7: Pediatric Diabetes & Early-Life Interventions

Pediatric diabetes requires age-specific diagnostic and care strategies. Developing systems exhibit altered immune ontogeny. Fluctuating autoantibody titers indicate early disease onset. Growth phases affect endocrine maturation timing. Early intervention supports long-term metabolic programming and reduces lifelong complications.

Pediatric Focus:

• Early Detection Indicators
• Growth-Related Metabolic Needs
• Family-Centered Care Models

Track 8: Diabetes-Related Cardiovascular Complications

Diabetes significantly elevates cardiovascular risk. Chronic hyperglycemia promotes endothelial dysfunction. Lipid imbalance drives atherogenic remodeling of blood vessels. Reduced vascular compliance indices impair circulation. Targeting cardiometabolic coupling lowers mortality and improves heart health outcomes.

Heart Health Domains:

• Vascular Risk Assessment
• Lipid–Glucose Interactions
• Preventive Cardiac Care

Track 9: Diabetic Neuropathy & Nerve Health

Nerve damage often develops silently in diabetes patients. Glucose excess disrupts axonal transport dynamics. Reduced blood flow induces neuroischemic stress. Altered myelin integrity patterns impair nerve conduction. Therapies aim to restore neural metabolic balance and preserve sensory function.

Neurological Sections:

• Sensory Loss Mechanisms
• Pain Management Approaches
• Nerve Regeneration Research

Track 10: Diabetic Nephropathy & Renal Protection

Kidney damage progresses gradually in diabetic individuals. Elevated glucose alters glomerular filtration kinetics. Protein leakage reflects basement membrane thickening. Inflammatory stress worsens renal microcirculation. Early intervention preserves nephron viability markers and delays renal failure.

Renal Care Themes:

• Early Kidney Damage Detection
• Filtration Function Monitoring
• Renoprotective Therapies

Track 11: Diabetic Retinopathy & Visual Health

Diabetic retinopathy remains a leading cause of vision loss. Microvascular injury causes retinal capillary dropout. Hypoxia stimulates angiogenic factor release. Structural damage alters ocular perfusion dynamics. Preventive screening ensures visual acuity sustainability and early treatment success.

Ophthalmic Focus Areas:

• Retinal Imaging Advances
• Vision Preservation Techniques
• Microvascular Protection

Track 12: Obesity, Diabetes & Energy Regulation

Excess body weight intensifies metabolic dysfunction. Adipose tissue releases adipokine imbalances that impair insulin action. Altered energy homeostasis loops disrupt glucose control. Chronic weight gain affects satiety signaling pathways. Improving caloric utilization efficiency supports diabetes prevention.

Metabolic Focus Domains:

• Weight-Related Risk Models
• Appetite Regulation Science
• Lifestyle Intervention Outcomes

Track 13: Digital Health & Diabetes Monitoring

Digital technologies are transforming diabetes care. Continuous monitoring improves glycemic variability analytics. Smart platforms use algorithmic dose optimization. Remote systems enhance patient adherence metrics. Integration supports real-time decision frameworks for personalized management.

Technology Domains:

• Wearable Innovations
• Data-Driven Care Models
• Remote Patient Monitoring

Track 14: Artificial Intelligence in Diabetes Care

Artificial intelligence enables predictive and personalized care. Machine learning identifies pattern recognition thresholds. Advanced models improve risk stratification accuracy. Automation supports clinical decision augmentation. Ethical implementation ensures transparent model interpretability and clinical trust.

AI Application Areas:

• Predictive Analytics
• Personalized Treatment Planning
• Ethical AI Deployment

Track 15: Nutritional Science & Glycemic Control

Nutrition directly influences blood glucose regulation. Macronutrient balance affects postprandial glycemia curves. Fiber intake modifies intestinal glucose diffusion. Meal timing impacts circadian metabolic alignment. Precision diets enhance nutrient-response predictability and patient adherence.

Nutritional Science Domains:

• Dietary Pattern Analysis
• Meal Timing Strategies
• Personalized Nutrition Models

Track 16: Physical Activity & Insulin Sensitivity

Regular physical activity improves metabolic health. Muscle contraction stimulates glucose transporter translocation. Training enhances oxidative capacity thresholds. Exercise reduces systemic insulin demand. Sustained movement promotes metabolic endurance adaptation and long-term glucose control.

Fitness & Activity Modules:

• Exercise Prescription Models
• Activity-Based Risk Reduction
• Lifestyle Integration Strategies

Track 17: Psychosocial Dimensions of Diabetes

Psychological health strongly influences diabetes outcomes. Chronic stress alters neuroendocrine feedback loops. Emotional burden affects treatment compliance behaviors. Social support improves self-management resilience. Addressing stigma enhances quality-of-life indices and care engagement.

Behavioral Health Areas:

• Stress Management Tools
• Patient Motivation Models
• Community Support Systems

Track 18: Health Equity & Diabetes Disparities

Health disparities significantly impact diabetes outcomes worldwide. Socioeconomic barriers drive care delivery inequities. Cultural factors influence health literacy gradients. Limited resources reduce preventive outreach effectiveness. Equity-focused policies promote inclusive care frameworks and sustainable solutions.

Equity & Policy Discussions:

• Access Improvement Strategies
• Community-Based Interventions
• Policy-Driven Solutions

Track 19: Pharmacological Advances in Diabetes Treatment

Pharmacological innovation continues to improve diabetes care. Novel agents enhance receptor agonism specificity. Combination therapies increase therapeutic synergy profiles. Optimized dosing reduces adverse effect incidence. Progress supports long-term efficacy stability and patient safety.

Therapeutic Development Areas:

• Drug Development Pipelines
• Safety Optimization
• Treatment Personalization

Track 20: Future Directions in Diabetes Research & Care

Future diabetes care emphasizes integrated and global solutions. Systems biology advances multi-omic data convergence. Personalized medicine enables precision intervention mapping. Collaboration accelerates translational research velocity. Sustainable models ensure global health impact scalability and innovation.

Future Pathways:

• Emerging Research Frontiers
• Integrated Care Systems
• Global Collaboration Models

Market Analysis

The global diabetes care market continues to expand steadily due to the rising prevalence of diabetes, increased life expectancy, and growing awareness of early diagnosis and long-term disease management. Rapid urbanization, lifestyle changes, and aging populations have contributed to a sustained increase in diabetes incidence across both developed and developing regions.

Advances in therapeutic options, continuous glucose monitoring systems, and digital health solutions are reshaping diabetes management. Innovation in glycemic control technologies, improved therapeutic adherence, and the integration of data-driven care models are driving market growth. Additionally, healthcare systems are increasingly prioritizing preventive care strategies to reduce long-term complications and economic burden.

The market is also witnessing strong momentum in personalized medicine, remote patient monitoring, and AI-supported decision tools. These trends align closely with the conference theme of building sustainable and inclusive approaches to diabetes care, highlighting the importance of accessibility, affordability, and long-term healthcare planning.

Global Diabetes Care Market Growth:

This graph illustrates the steady growth of the global diabetes care market from 2020 to 2026. The market size shows a consistent upward trend, reflecting increasing demand for diabetes-related drugs, monitoring devices, and care services. Growth is supported by improved diagnostic coverage, wider adoption of glucose monitoring technologies, and increased healthcare expenditure. The projected rise toward 2026 highlights the expanding opportunities for innovation and investment in diabetes care solutions.

Diabetes Market Segmentation by Product Type:

This graph represents the distribution of the diabetes care market by product category. Pharmaceutical therapies account for the largest share, driven by long-term medication needs and expanding treatment options. Medical devices, including glucose monitoring and insulin delivery systems, form a significant portion of the market. Diagnostics contribute steadily through early detection and monitoring tools, while digital health solutions—though currently smaller—are rapidly gaining importance due to their role in remote monitoring, patient engagement, and personalized care delivery.
 

Abstract Submission and Registration

• All abstracts must be submitted in English.
• The abstract text should not exceed 500 words.
• Titles should be concise, written in sentence case, and reflect the core objective of the study
• Provide full names, affiliations, and professional designations of all authors
• Clearly identify the presenting author
• A brief biography of the presenting author (maximum 150 words) along with a professional photograph is required
• Submissions may focus on diabetes prevention, clinical diabetology, endocrinology, healthcare delivery models, nutrition science, digital health, or related interdisciplinary research

Scientific Review Process

All submitted abstracts will undergo evaluation by the Scientific Review Committee based on originality, scientific relevance, and methodological quality. Authors will be notified regarding acceptance status, presentation format, or revision requests via email, generally within 24–48 hours of submission. Accepted abstracts may be scheduled for oral presentations, poster sessions, or interactive discussions depending on scientific scope.

Publication Opportunities

Accepted abstracts will be published in the official conference proceedings and may be considered for inclusion in associated scientific journals, conference compendiums, or diabetes-focused healthcare publications, subject to editorial review.

Abstract Submission Link:

https://diabetic.healthconferences.org/abstract-submission.php

Registration

Upon abstract acceptance, participants are required to complete conference registration through the official registration platform. Registration grants access to scientific sessions, keynote lectures, workshops, networking events, and official participation certification. Early registration is recommended to ensure availability and optimal conference planning.

Registration Link:

https://diabetic.healthconferences.org/registration.php

Visa Guidelines

The organizing committee of the 35^th International Diabetes and Healthcare Conference 2026 does not directly manage visa applications for entry into France. However, comprehensive documentation support is provided to assist registered participants with their visa process.

Upon request, the following official documents can be issued to support visa applications:

• Official Letter of Invitation
• Abstract Acceptance Confirmation
• Registration Confirmation and PAyment Receipt

Visa requirements vary according to nationality and local regulations of the French Embassy or Consulate. Participants are strongly encouraged to initiate their visa application process well in advance of the conference dates to avoid delays.

Letter of Invitation

The Letter of Invitation confirms conference participation through abstract acceptance and/or completed registration. This document is issued in English and may be submitted as supporting evidence during the visa application process. Please note that issuance of an invitation letter does not guarantee visa approval, as all decisions are made solely by the respective immigration authorities.

Visa Support Contact

For visa-related queries or requests for official supporting documents, please contact:
meevents@memeetings.com

Past Conference

The 34^th International Diabetes and Healthcare Conference was held on August 28–29, 2025, in London, UK, bringing together a diverse international assembly of endocrinologists, diabetologists, clinical researchers, public health practitioners, and industry representatives.

This event examined contemporary challenges in diabetes science and care, with participants engaging in discussions on glycemic regulation, diabetes complications, and integrated strategies toward effective long-term management. A broad range of topics included clinical advances in metabolic risk evaluation, implementation of evidence-based care models, and the growing role of digital health platforms in supporting patient-centered care.

Highlights included sessions on diabetic complications, emerging pharmacotherapies, and the integration of biomarker research into clinical practice. Presenters shared insights into recent findings on diabetic microvascular and macrovascular outcomes, reinforcing the importance of early detection and personalized intervention approaches.

The meeting also featured workshops that emphasized translational applications of novel diagnostics and insulin delivery technologies, enabling clinicians and researchers to bridge laboratory discovery with real-world patient impact. Attendees valued the networking opportunities and collaborative discussions that positioned future research priorities within a global healthcare context.

Overall, the 2025 conference underscored the dynamic nature of diabetes research and the critical need for multidisciplinary partnerships to tackle evolving clinical and preventive challenges.

Scientific Highlights and Focus Areas from the 2025 Conference

In addition to the main series event above, multiple diabetes-focused scientific meetings were conducted in 2025 that contributed to the global discourse on metabolic disease and care pathways:

• A major congress on diabetes, endocrinology, and primary healthcare held in Paris, France concentrated on current trends and advances in diabetes research and featured sessions on obesity, cardiovascular risk, gestational diabetes, and diabetic foot pathophysiology.
   
• A hybrid International Conference on Diabetes and Endocrinology in Bangkok, Thailand addressed innovations in diabetes procedures and treatment approaches, emphasizing translational care models and multidisciplinary interventions.
   
• Specialty meetings such as the Diabetic Nutrition 2025 Conference in Italy explored topics including molecular endocrinology, digital diabetes health technologies, and new insulin delivery systems, broadening the scientific landscape surrounding metabolic health.
   
• These collective events reflect the global momentum behind diabetes research and clinical innovation, reinforcing themes that feed into the ongoing development of international care guidelines and preventive strategies.

Upcoming 2026 Conference:

Building on the scientific insights and collaborative momentum of previous meetings, the 35^th International Diabetes and Healthcare Conference, scheduled for June 15–16, 2026, in Paris, France, will further expand discussions on future-ready diabetes care. The upcoming edition will emphasize innovative strategies addressing glycemic sustainability, long-term metabolic resilience, and inclusive healthcare delivery models.

With a strong focus on prevention, the 2026 conference will explore how advances in translational research, digital health integration, and population-based interventions can be aligned to reduce the global diabetes burden. By bringing together multidisciplinary expertise, the conference aims to foster actionable solutions that support sustainable, equitable, and evidence-driven diabetes care worldwide.